Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
OBJECTIVE Cytomegalovirus (CMV) infection is the most frequent congenital infection and a major cause of long-term neurological morbidity. The aim of this meta-analysis was to calculate the pooled rates of vertical transmission and fetal consequences according to the timing of primary maternal infection. DATA SOURCES MEDLINE, Scopus, Cochrane Library and grey literature sources were searched from inception until January 2020. STUDY ELIGIBILITY CRITERIA Cohort and observational studies reporting timing of maternal CMV infection and rate of vertical transmission or fetal consequences were included. The primary outcomes were (i) vertical transmission and ii) fetal insult, defined either as prenatal findings from the central nervous system (CNS) leading to termination of pregnancy, or the presence of neurological symptoms at birth. The secondary outcomes included (i) sensorineural hearing loss (SNHL) and/or neurodevelopmental delay at follow-up, and (ii) prenatal CNS ultrasound findings STUDY APPRAISAL AND SYNTHESIS METHODS: The pooled rates of the outcomes of interest with their 95% confidence intervals [CI], were calculated for primary maternal infection at the (i) preconceptional period, (ii) periconceptional period, (iii) first trimester, (iv) second trimester and (v) third trimester. RESULTS Seventeen studies were included. The pooled rates of vertical transmission (10 studies, 2942 fetuses) at the preconceptional period, periconceptional period, first, second and third trimester were 5.5% (95%CI: 0.1% to 10.8%), 21.0% (95%CI: 8.4% to 33.6%), 36.8% (95%CI: 31.9% to 41.6%), 40.3% (95%CI: 35.5% to 45.1%) and 66.2% (95%CI: 58.2% to 74.1%), respectively. The pooled rates of fetal insult in case of transmission (10 studies, 796 fetuses) were 28.8% (95%CI: 2.4% to 55.1%), 19.3% (95%CI: 12.2% to 26.4%), 0.9% (95%CI: 0% to 2.4%), and 0.4% (95%CI: 0% to 1.5%), for maternal infection at the periconceptional period , first, second and third trimester, respectively. The pooled rates of SNHL for maternal infection at the first, second and third trimester were 22.8% (95%CI: 15.4% to 30.2%), 0.1% (95%CI: 0% to 0.8%), and 0% (95%CI: 0% to 0.1%), respectively. CONCLUSIONS Vertical transmission after maternal primary CMV infection increases with advancing pregnancy, starting from the preconceptional period. However, severe fetal consequences are rare after first-trimester infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Metaprop: a Stata command to perform meta-analysis of binomial data
Nyaga, V. N., Arbyn, M., & Aerts, M. (2014) · Archives of Public Health · doi:10.1186/2049-3258-72-39 · Cited by 2,139
Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Kenneson, A., & Cannon, M. J. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.535 · Cited by 1,720
Stagno, S. (1986) · JAMA · doi:10.1001/jama.256.14.1904 · Cited by 960
Stagno, S., Pass, R. F., Dworsky, M. E., Henderson, R. E., Moore, E. G., Walton, P. D., & Alford, C. A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204223061601 · Cited by 688
Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant
Revello, M. G., & Gerna, G. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.680-715.2002 · Cited by 618
Cheeran, M. C.-J., Lokensgard, J. R., & Schleiss, M. R. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-08 · Cited by 516
A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus
Revello, M. G., Lazzarotto, T., Guerra, B., Spinillo, A., Ferrazzi, E., Kustermann, A., Guaschino, S., Vergani, P., Todros, T., Frusca, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310214 · Cited by 489
Pass, R. F., Fowler, K. B., Boppana, S. B., Britt, W. J., & Stagno, S. (2006) · Journal of Clinical Virology · doi:10.1016/j.jcv.2005.09.015 · Cited by 479
Metadata
- Authors
- Chatzakis, C., Ville, Y., Makrydimas, G., Dinas, K., Zavlanos, A., & Sotiriadis, A.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 223
- Issue
- 6
- Pages
- 870-883.e11
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W3027100209
- Cited by
- 229
- References
- 39
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences. https://app.cochat.ai/papers/10.1016/j.ajog.2020.05.038
- The paper
- Chatzakis, C., Ville, Y., Makrydimas, G., Dinas, K., Zavlanos, A., & Sotiriadis, A. (2020). Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2020.05.038
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.